RAPPORT THERAPEUTICS INC (RAPP) Stock Earnings & Estimates
USA - NASDAQ:RAPP - US75383L1026 - Common Stock
24.99 USD
+0.12 (+0.48%)
24.99 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | ||||
| EBITDA YoY % growth | -10.352M | -36.067M -248.41% | -82.216M -127.95% | N/A -60.36% | N/A -35.33% | N/A -50.18% | |
| EBIT YoY % growth | -10.367M | -36.179M -248.98% | -83.055M -129.57% | N/A -58.35% | N/A -44.94% | N/A -11.64% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 18.34% | N/A -29.70% | N/A -20.24% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.79 -58.18% | -0.82 -43.40% | -0.93 -36.50% | -0.96 -28.18% | -1.01 -27.68% | -1.03 -25.62% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -34.644M -64.50% | -40.054M -76.59% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.592M -59.85% | -38.897M -65.37% | -47.071M -73.64% | -49.37M -67.38% | -54.927M -58.79% | -56.983M -46.50% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.75 55.88% | -0.85 | 0.10 | 11.59% |
| Q1 2025 Q2Q % growth | -0.68 | -0.78 | 0.10 | 12.28% |
| Q4 2024 Q2Q % growth | -0.57 | -0.64 | 0.07 | 10.59% |
| Q3 2024 Q2Q % growth | -0.50 | -0.59 | 0.09 | 14.90% |
| Q2 2024 Q2Q % growth | -1.70 | -0.69 | -1.01 | -146.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.61% | 8.6% | 3.12% | 8.02% |
| Revenue | N/A | N/A | N/A | N/A |